The large number of altered proteins belonging to the dystrophin complexome supports the findings from previous comparative proteomics studies [94], [95], [96], [97], [98], [99] and suggests a number of robust and universal biomarkers of muscular dystrophy [100]. This evidence concerns the gene DMD and muscular dystrophy.